Published in Dev Cell on September 01, 2001
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell (2008) 14.17
Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet (2009) 12.08
Epigenetic reprogramming and induced pluripotency. Development (2009) 4.90
Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol (2005) 4.54
Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol (2008) 4.07
De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol (2008) 3.33
Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res (2002) 2.49
Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol Cell Biol (2005) 2.32
Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol Cell Biol (2007) 2.15
Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol (2006) 2.13
Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol (2005) 2.07
DNA methylation in development and human disease. Mutat Res (2008) 1.74
The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression. Proc Natl Acad Sci U S A (2002) 1.52
Retracted Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression. Mol Cell Biol (2006) 1.45
Canonical Wnt/β-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem Cells (2010) 1.43
A tripartite transcription factor network regulates primordial germ cell specification in mice. Nat Cell Biol (2013) 1.36
Histone tails regulate DNA methylation by allosterically activating de novo methyltransferase. Cell Res (2011) 1.24
Lsh participates in DNA methylation and silencing of stem cell genes. Stem Cells (2009) 1.20
Targeting of de novo DNA methylation throughout the Oct-4 gene regulatory region in differentiating embryonic stem cells. PLoS One (2010) 1.17
Tpt1 activates transcription of oct4 and nanog in transplanted somatic nuclei. Curr Biol (2007) 1.17
Expression profiling of nuclear receptors in human and mouse embryonic stem cells. Mol Endocrinol (2009) 1.16
Role of Oct4 in maintaining and regaining stem cell pluripotency. Stem Cell Res Ther (2010) 1.12
Novel microRNA candidates and miRNA-mRNA pairs in embryonic stem (ES) cells. PLoS One (2008) 1.11
GCNF-dependent repression of BMP-15 and GDF-9 mediates gamete regulation of female fertility. EMBO J (2003) 1.06
Transcriptional regulation of the Oct4 gene, a master gene for pluripotency. Histol Histopathol (2010) 1.01
Nuclear Receptors in Regulation of Mouse ES Cell Pluripotency and Differentiation. PPAR Res (2007) 1.00
Quantitative proteome analysis of pluripotent cells by iTRAQ mass tagging reveals post-transcriptional regulation of proteins required for ES cell self-renewal. Mol Cell Proteomics (2010) 0.96
Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4. Stem Cells (2011) 0.94
Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts. Genes Dev (2013) 0.91
Dnmt3a1 upregulates transcription of distinct genes and targets chromosomal gene clusters for epigenetic silencing in mouse embryonic stem cells. Mol Cell Biol (2011) 0.91
Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network. Cell Mol Life Sci (2015) 0.90
Implication of DNA demethylation and bivalent histone modification for selective gene regulation in mouse primordial germ cells. PLoS One (2012) 0.89
Oct4 is required ~E7.5 for proliferation in the primitive streak. PLoS Genet (2013) 0.89
Cloning and Characterization of 3.1kb Promoter Region of the Oct4 Gene from the Fischer 344 Rat. Open Stem Cell J (2009) 0.88
Role of gene methylation in antitumor immune response: implication for tumor progression. Cancers (Basel) (2011) 0.87
The microRNA miR-235 couples blast-cell quiescence to the nutritional state. Nature (2013) 0.85
Dicer deficiency reveals microRNAs predicted to control gene expression in the developing adrenal cortex. Mol Endocrinol (2013) 0.85
The varied roles of nuclear receptors during vertebrate embryonic development. Nucl Recept Signal (2003) 0.83
Mouse Germ Cell Development in-vivo and in-vitro. Biomark Insights (2007) 0.82
Learning biomarkers of pluripotent stem cells in mouse. DNA Res (2011) 0.82
Selective proapoptotic activity of polyphenols from red wine on teratocarcinoma cell, a model of cancer stem-like cell. Invest New Drugs (2009) 0.82
Postnatal male germ-cell expression of cre recombinase in Tex101-iCre transgenic mice. Genesis (2010) 0.81
Evolution of gene regulation of pluripotency--the case for wiki tracks at genome browsers. Biol Direct (2010) 0.81
0610009K11Rik, a testis-specific and germ cell nuclear receptor-interacting protein. Biochem Biophys Res Commun (2007) 0.80
The orphan nuclear receptors at their 25-year reunion. J Mol Endocrinol (2013) 0.80
Extra-germ cell expression of mouse nuclear receptor subfamily 6, group A, member 1 (NR6A1). Biol Reprod (2009) 0.80
Stem cell approaches for the treatment of type 1 diabetes mellitus. Transl Res (2010) 0.80
Transcription factor cCP2 controls gene expression in chicken embryonic stem cells. Nucleic Acids Res (2004) 0.79
Epigenetic reprogramming of the germ cell nuclear factor gene is required for proper differentiation of induced pluripotent cells. Stem Cells (2013) 0.79
Minireview: the diverse roles of nuclear receptors in the regulation of embryonic stem cell pluripotency. Mol Endocrinol (2013) 0.78
The ligand binding domain of GCNF is not required for repression of pluripotency genes in mouse fetal ovarian germ cells. PLoS One (2013) 0.78
Transcriptional regulation of the hypocretin/orexin gene by NR6A1. Biochem Biophys Res Commun (2010) 0.78
The coregulator Alien. Nucl Recept Signal (2007) 0.77
RAR/RXR binding dynamics distinguish pluripotency from differentiation associated cis-regulatory elements. Nucleic Acids Res (2015) 0.77
Sex determination in mammalian germ cells. Asian J Androl (2015) 0.77
Germ cell nuclear factor regulates gametogenesis in developing gonads. PLoS One (2014) 0.77
Germ Cell Nuclear Factor (GCNF) Represses Oct4 Expression and Globally Modulates Gene Expression in Human Embryonic Stem (hES) Cells. J Biol Chem (2016) 0.76
Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases. J Exp Neurosci (2016) 0.76
Chromatin changes in dicer-deficient mouse embryonic stem cells in response to retinoic acid induced differentiation. PLoS One (2013) 0.76
The Pou5f1 distal enhancer is sufficient to drive Pou5f1 promoter-EGFP expression in embryonic stem cells. Int J Dev Biol (2013) 0.75
GCNF-dependent activation of cyclin D1 expression via repression of Mir302a during ESC differentiation. Stem Cells (2014) 0.75
The ability of mouse nuclear transfer embryonic stem cells to differentiate into primordial germ cells. Genet Mol Biol (2015) 0.75
Identification of CHD1L as an Important Regulator for Spermatogonial Stem Cell Survival and Self-Renewal. Stem Cells Int (2016) 0.75
A Structural Investigation into Oct4 Regulation by Orphan Nuclear Receptors, Germ Cell Nuclear Factor (GCNF) and Liver Receptor Homolog-1 (LRH-1). J Mol Biol (2016) 0.75
Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40
Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development (1996) 7.00
Specific interaction between enhancer-containing molecules and cellular components. Cell (1984) 6.96
Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells (2001) 4.63
Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol (1994) 3.88
Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev Growth Differ (1999) 3.56
New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev (1998) 3.43
Cell type-specific transcriptional enhancement in vitro requires the presence of trans-acting factors. EMBO J (1985) 2.70
A transcription factor which binds to the enhancers of SV40, immunoglobulin heavy chain and U2 snRNA genes. Nature (1987) 2.48
Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J (1990) 2.19
Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J Biol Chem (2000) 2.04
Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. Mamm Genome (2001) 1.89
Simplified generation of targeting constructs using ET recombination. Nucleic Acids Res (1999) 1.79
In line with our ancestors: Oct-4 and the mammalian germ. Bioessays (1998) 1.79
Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles. EMBO J (1997) 1.73
Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell (2000) 1.69
Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2. Development (2001) 1.63
Oct-4: control of totipotency and germline determination. Mol Reprod Dev (2000) 1.57
Spatiotemporal expression patterns of chicken ovalbumin upstream promoter-transcription factors in the developing mouse central nervous system: evidence for a role in segmental patterning of the diencephalon. Proc Natl Acad Sci U S A (1994) 1.54
Lysozyme gene activity in chicken macrophages is controlled by positive and negative regulatory elements. Nucleic Acids Res (1987) 1.54
VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J (2000) 1.52
Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol Cell (2001) 1.50
Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan. J Clin Invest (1990) 1.49
Co-repressors 2000. FASEB J (2000) 1.48
The molecular biology of Oct-4 in the early mouse embryo. Mol Hum Reprod (1998) 1.46
Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol Cell Biol (1999) 1.42
Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells. Oncogene (2008) 1.33
Regulation of the Oct-4 gene by nuclear receptors. Nucleic Acids Res (1994) 1.32
Loss of orphan receptor germ cell nuclear factor function results in ectopic development of the tail bud and a novel posterior truncation. Mol Cell Biol (2001) 1.30
Long-range reactive dynamics in myoglobin. Phys Rev Lett (2001) 1.28
Cloning of a novel orphan receptor (GCNF) expressed during germ cell development. Mol Endocrinol (1994) 1.26
Molecular mechanisms of COUP-TF-mediated transcriptional repression: evidence for transrepression and active repression. Mol Cell Biol (1996) 1.23
Interferon-gamma regulation of Clara cell gene expression: in vivo and in vitro. Am J Physiol (1997) 1.19
The mouse bone morphogenetic protein-4 gene. Analysis of promoter utilization in fetal rat calvarial osteoblasts and regulation by COUP-TFI orphan receptor. J Biol Chem (1995) 1.17
NeP1. A ubiquitous transcription factor synergizes with v-ERBA in transcriptional silencing. J Mol Biol (1993) 1.14
Structure, expression and chromosomal location of the Oct-4 gene. Mech Dev (1991) 1.12
Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J (1996) 1.10
BKCa channels activating at resting potential without calcium in LNCaP prostate cancer cells. J Membr Biol (2006) 1.10
The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U. J Biol Chem (1997) 1.09
Mouse Oct-1 contains a composite homeodomain of human Oct-1 and Oct-2. Nucleic Acids Res (1993) 1.07
Optical sensor arrays for odor recognition. Biosens Bioelectron (1998) 1.06
Developmental regulation of the orphan receptor COUP-TF II gene in spinal motor neurons. Development (1994) 1.05
Nuclear receptors: structure, function and involvement in disease. Int J Biochem Cell Biol (1997) 1.04
Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J Biol Chem (2000) 1.03
Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol Endocrinol (1995) 1.00
Phage display screening reveals an association between germline-specific transcription factor Oct-4 and multiple cellular proteins. J Mol Biol (2000) 0.99
Characterization of germ cell-specific expression of the orphan nuclear receptor, germ cell nuclear factor. Endocrinology (1997) 0.99
Germ cell nuclear factor is a response element-specific repressor of transcription. Biochem Biophys Res Commun (1998) 0.98
Crystallization of redox-insensitive Oct1 POU domain with different DNA-response elements. Acta Crystallogr D Biol Crystallogr (2001) 0.97
Spatial and temporal expression of the 72-kDa type IV collagenase (MMP-2) correlates with development and differentiation of valves in the embryonic avian heart. Dev Dyn (1997) 0.95
Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I. J Biol Chem (1994) 0.92
Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity. Mol Cell Biol (1999) 0.92
Cooperative interaction of chicken lysozyme enhancer sub-domains partially overlapping with a steroid receptor binding site. Nucleic Acids Res (1989) 0.92
Cloning, expression analysis and chromosomal localization of the human nuclear receptor gene GCNF. FEBS Lett (1998) 0.90
A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes. Mol Cell Biol (1990) 0.90
Binding of Sp1 and Sp3 transcription factors to the Oct-4 gene promoter. Cell Mol Biol (Noisy-le-grand) (1999) 0.90
Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor. Biochem Soc Trans (2000) 0.89
The v-erbA oncogene (review). Int J Mol Med (1999) 0.88
Oct-4: lessons of totipotency from embryonic stem cells. Cells Tissues Organs (1999) 0.88
Germ cell nuclear factor is a transcriptional repressor essential for embryonic development. Front Biosci (2001) 0.88
A rapid method combining a functional test of fusion proteins in vivo and their purification. Biotechniques (1994) 0.87
Negative regulation by the R2 element of the MHC class I enhancer in adenovirus-12 transformed cells correlates with high levels of COUP-TF binding. Oncogene (1994) 0.87
gamma-Ray wavelength standard for atomic scales. Phys Rev Lett (2000) 0.87
Laser secondary neutral mass spectrometry for copper detection in micro-scale biopsies. J Mass Spectrom (2009) 0.87
The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies. Br J Pharmacol (2014) 0.86
Mouse protamine genes are candidate targets for the novel orphan nuclear receptor, germ cell nuclear factor. Mol Reprod Dev (1998) 0.85
Sirtuin family: a link to metabolic signaling and senescence. Curr Med Chem (2010) 0.84
At least three subdomains of v-erbA are involved in its silencing function. Mol Endocrinol (1997) 0.84
A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha. Endocrinology (2001) 0.84
Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer. Anticancer Res (2000) 0.83
Multiple receptor interaction domains of GRIP1 function in synergy. Nucleic Acids Res (1998) 0.83
Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells. Proc Natl Acad Sci U S A (2008) 0.83
Oct-4: more than just a POUerful marker of the mammalian germline? APMIS (1998) 0.83
Cell-cell fusion as a means to establish pluripotency. Ernst Schering Res Found Workshop (2006) 0.82
Targeting heat shock proteins in prostate cancer. Curr Med Chem (2013) 0.80
Repression of Oct-4 during embryonic cell differentiation correlates with the appearance of TRIF, a transiently induced DNA-binding factor. Cell Mol Biol (Noisy-le-grand) (1999) 0.79
Translation of adenovirus serotype 2 late messenger RNAs. J Mol Biol (1982) 0.79
Germ cell nuclear factor. Int J Biochem Cell Biol (2001) 0.78
Detection of potential ligands for nuclear receptors in cellular extracts. Endocrinology (1994) 0.78
An inhibitory region of the DNA-binding domain of thyroid hormone receptor blocks hormone-dependent transactivation. Mol Endocrinol (1998) 0.77
EcR interacts with corepressors and harbours an autonomous silencing domain functional in both Drosophila and vertebrate cells. J Steroid Biochem Mol Biol (1999) 0.77
Batch cultivation of Methylosinus trichosporium OB3B: IV. Production of hydrogen-driven soluble or particulate methane monooxygenase activity. Biotechnol Bioeng (1995) 0.77
Biodegradation of polystyrene, poly(metnyl methacrylate), and phenol formaldehyde. Appl Environ Microbiol (1979) 0.76
Silencing subdomains of v-ErbA interact cooperatively with corepressors: involvement of helices 5/6. Mol Endocrinol (2000) 0.76
Co-activator and co-repressor interplay on the human androgen receptor. Andrologia (2005) 0.76
[Not Available]. Acta Genet Stat Med (1957) 0.75
[Comparative study based on 2 reagents for thymol turbidity reaction]. Med Lab (Stuttg) (1966) 0.75
The influence of diphenylhydantoin (Dilantin) on the development of atherosclerosis in rabbits. J Atheroscler Res (1967) 0.75
The pH dependence of binding of alpha,alpha'-dibromo-p-xylenesulfonic acid to lysozyme. Int J Pept Protein Res (1976) 0.75
The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites. J Endocrinol (2000) 0.75
[A simple control procedure for the supervision of various laboratory examinations]. Med Lab (Stuttg) (1966) 0.75
Multiresidue method for analysis of pesticides in liquid whole milk. J AOAC Int (1998) 0.75
Incorporation of labelled glucose and glycerol into phospholipids and triglycerides by rat and rabbit aorta. Atherosclerosis (1978) 0.75
A rapid one-step method to purify baculovirus-expressed human estrogen receptor to be used in the analysis of the oxytocin promoter. Gene (1994) 0.75
Some in vivo effects of chalone (mitotic inhibitor) obtained from lymphoid tissues. Natl Cancer Inst Monogr (1973) 0.75
Effects of diphenylhydantoin upon the plasma free fatty acid response induced by hormones. Proc Soc Exp Biol Med (1965) 0.75